THE PRESENT SITUATION OF IMMUNOTOXICITY STUDY IN DEVELOPMENT OF DRUGS

Immunotoxicity study is not required for development of a new drug in GLP guidelines in Japan. However, the need of such a study is growing with the progress of development of biotechnology products, antiviral agents against AIDS, immunotherapeutics, etc. According to the result of the questionnaire...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Toxicologic Pathology 1995/09/30, Vol.8(3), pp.257-263
1. Verfasser:	Maki, Eiji
Format:	Artikel
Sprache:	eng
Schlagworte:	Biotechnology products Histopathological change Immunotherapeutics Immunotoxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!